Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
&NA;
1994.
Clozapine.
Reactions Weekly,
Vol. &NA;,
Issue. 499,
p.
6.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1995.
Vol. 19,
Issue. ,
p.
40.
Moritz, S.
Naber, D.
Krausz, M.
Lambert, M.
and
Andresen, B.
1999.
Leponex.
p.
90.
Moritz, Steffen
Iverson, Grant L.
and
Woodward, Todd S.
2003.
Reliable Change Indexes for Memory Performance in Schizophrenia as a Means to Determine Drug-Induced Cognitive Decline.
Applied Neuropsychology,
Vol. 10,
Issue. 2,
p.
115.
Lublin, Henrik
Eberhard, Jonas
and
Levander, Sten
2005.
Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics.
International Clinical Psychopharmacology,
Vol. 20,
Issue. 4,
p.
183.
Neha
Sodhi, Rupinder K.
Jaggi, Amteshwar S.
and
Singh, Nirmal
2014.
Animal models of dementia and cognitive dysfunction.
Life Sciences,
Vol. 109,
Issue. 2,
p.
73.
Singh, Aditya
Ansari, Vaseem Ahamad
Ansari, Tarique Mahmood
Hasan, Syed Misabah
Ahsan, Farogh
Singh, Kuldeep
Wasim, Rufaida
Maheshwari, Shubhrat
and
Ahmad, Asad
2023.
Consequence of Dementia and Cognitive Impairment by Primary
Nucleation Pathway.
Hormone and Metabolic Research,
Vol. 55,
Issue. 05,
p.
304.
Singh, Aditya
Ansari, Vaseem A.
Mahmood, Tarique
Ahsan, Farogh
and
Maheshwari, Shubhrat
2024.
Repercussion of Primary Nucleation Pathway: Dementia and Cognitive
Impairment.
Current Aging Science,
Vol. 17,
Issue. 3,
p.
196.
eLetters
No eLetters have been published for this article.